These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1405768)
1. Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period. Gertz MA; Kyle RA; Thibodeau SN Mayo Clin Proc; 1992 May; 67(5):428-40. PubMed ID: 1405768 [TBL] [Abstract][Full Text] [Related]
2. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Kyle RA; Spittell PC; Gertz MA; Li CY; Edwards WD; Olson LJ; Thibodeau SN Am J Med; 1996 Oct; 101(4):395-400. PubMed ID: 8873510 [TBL] [Abstract][Full Text] [Related]
3. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Fine NM; Arruda-Olson AM; Dispenzieri A; Zeldenrust SR; Gertz MA; Kyle RA; Swiecicki PL; Scott CG; Grogan M Am J Cardiol; 2014 May; 113(10):1723-7. PubMed ID: 24698461 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation. Banerjee D; Roeker LE; Grogan M; Swiecicki P; Poterucha J; Heimbach J; Zeldenrust S; Gertz M; Edwards B; Daly R; Klarich KW; Dispenzieri A Prog Transplant; 2017 Sep; 27(3):246-250. PubMed ID: 29187090 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive risk stratification of patients with transthyretin amyloidosis. Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252 [TBL] [Abstract][Full Text] [Related]
6. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285 [TBL] [Abstract][Full Text] [Related]
7. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis. Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669 [TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Rajkumar SV; Gertz MA; Kyle RA Am J Med; 1998 Mar; 104(3):232-7. PubMed ID: 9552085 [TBL] [Abstract][Full Text] [Related]
9. Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene. Augustin S; Llige D; Andreu A; González A; Genescà J Eur J Clin Invest; 2007 Aug; 37(8):673-8. PubMed ID: 17635579 [TBL] [Abstract][Full Text] [Related]
10. [Hereditary amyloid cardiomyopathy related to a mutation at transthyretin protein number 111. A clinical, genetic and echocardiographic study of an affected Danish family]. Svendsen IH; Steensgaard-Hansen F; Nordvåg BY Ugeskr Laeger; 1999 Sep; 161(36):4995-9. PubMed ID: 10489791 [TBL] [Abstract][Full Text] [Related]
11. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis. Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M; Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and origin of amyloid in kidney biopsies. von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448 [TBL] [Abstract][Full Text] [Related]
13. Hereditary amyloid polyneuropathy in north west Ireland. Staunton H; Dervan P; Kale R; Linke RP; Kelly P Brain; 1987 Oct; 110 ( Pt 5)():1231-45. PubMed ID: 3676699 [TBL] [Abstract][Full Text] [Related]
14. Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy. Nelson LM; Penninga L; Villadsen GE; Mølgaard H; Eiskjaer H; Hillingsø JG; Rasmussen A Clin Transplant; 2015 Dec; 29(12):1098-104. PubMed ID: 26361241 [TBL] [Abstract][Full Text] [Related]
15. Cardiac amyloidosis diagnosed by endomyocardial biopsy. Clinical, histopathological, immunohistochemical and ultrastructural studies. Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Michalak E; Jakubowska E; Sobieszczańska-Małek M; Deptuch T; Walczak E; Wagner T; Walski M; Rózański J; Kiedrowski M; Lubiszewska B; Hoffman P; Rózyłło W Kardiol Pol; 2005 Jul; 63(7):20-35. PubMed ID: 16136426 [TBL] [Abstract][Full Text] [Related]
16. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis. Flodrova P; Flodr P; Pika T; Vymetal J; Holub D; Dzubak P; Hajduch M; Scudla V Pathology; 2018 Apr; 50(3):261-268. PubMed ID: 29448998 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy. Li K; Kyle RA; Dyck PJ Am J Pathol; 1992 Jul; 141(1):217-26. PubMed ID: 1321563 [TBL] [Abstract][Full Text] [Related]